Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
Desser L; Holomanova D; Zavadova E; Pavelka K; Mohr T; Herbacek I; Cancer Chemotherapy And Pharmacology, 2001, vol. 47 Suppl, p S10, ISSN 03445704. ISBN 03445704.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef